Gabriel Altit, Henry C. Lee, Susan Hintz, Theresa A. Tacy, Jeffrey A. Feinstein, Shazia Bhombal
Montreal Children’s Hospital and McGill University. Stanford University and Lucile Packard Children’s Hospital.
Canada and United States
Journal of Perinatology
J Perinatol 2018; 38: 361-367
DOI: 10.1038/s41372-017-0025-3
Abstract
Objective: Pulmonary hypertension (PH) is associated with bronchopulmonary dysplasia (BPD). Screening strategies, a thorough investigation of co-morbidities, and multidisciplinary involvement prior to anti-PH medications have been advocated by recent guidelines. We sought to evaluate current practices of neonatologists caring for premature infants with PH.
Design: Electronic survey of American Academy of Pediatrics neonatology members.
Results: Among 306 neonatologist respondents, 38% had an institutional screening protocol for patients with BPD; 83% screened at 36 weeks for premature neonates on oxygen/mechanical ventilation. In those practicing more than 5 years, 54% noted increasing numbers of premature infants diagnosed with PH. Evaluation for PH in BPD patients included evaluations for micro-aspiration (41%), airways anomalies (29%), and catheterization (10%). Some degree of acquired pulmonary vein stenosis was encountered in 47%. A majority (90%) utilized anti-PH medications during the neonatal hospitalization.
Conclusions: Screening for PH in BPD, and subsequent evaluation and management is highly variable.
Category
Class III. Pulmonary Hypertension Associated with Lung Disease
Class II. Pulmonary Hypertension Associated with Pulmonary Vein Stenosis
Diagnostic Testing for Pulmonary Vascular Disease. Non-invasive Testing
Diagnostic Testing for Pulmonary Vascular Disease. Invasive Testing
Age Focus: Pediatric Pulmonary Vascular Disease
Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication
Article Access
Free PDF File or Full Text Article Available Through PubMed or DOI: No